The dynamics of Fe2+ and nitric oxide (NO) metabolites levels in exhaled breath condensate (EBC) in long-term smokers

E. A. Zaprudnova, A. G. Gladilkina, S. K. Soodaeva, I. A. Klimanov, A. V. Lisitsa (Vladimir, Moscow, Russian Federation)

Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Session: Tobacco, bronchial tubes and the lung
Session type: E-Communication Session
Number: 4508
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. A. Zaprudnova, A. G. Gladilkina, S. K. Soodaeva, I. A. Klimanov, A. V. Lisitsa (Vladimir, Moscow, Russian Federation). The dynamics of Fe2+ and nitric oxide (NO) metabolites levels in exhaled breath condensate (EBC) in long-term smokers. Eur Respir J 2009; 34: Suppl. 53, 4508

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The investigation of stable nitric oxide (NO) metabolites correlation in exhaled breath condensate (EBC) in Chernobyl clean-up workers (CCUW) with COPD
Source: Annual Congress 2011 - Work-related respiratory diseases and specific exposures
Year: 2011

Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006

Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC)
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways?
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006

Total nitrate/nitrite level (TNN) in exhaled breath condensate (EBC) as a comprehensive marker of nitric oxide synthesis in respiratory tract
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Year: 2007


The changes of nitric oxide metabolism and soluble forms of differentiated antigens levels in exhaled breath condensate (EBC) in Chernobyl clean-up workers with COPD
Source: Annual Congress 2009 - Occupational exposures and disease II
Year: 2009

Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy.
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019

Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


The oropharyngeal contribution to exhaled nitric oxide (eNO) levels
Source: Eur Respir J 2001; 18: Suppl. 33, 460s
Year: 2001

Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 506s
Year: 2002

Exhaled nitric oxide (eNO) and acidity of exhaled breath condensate (EBC pH) of children with asthma, cystic fibrosis (CF) and healthy controls
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005

Exhaled nitric oxide and exhaled breath condensate pH in smoking asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009


Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

Concentration of nitric oxide in exhaled air (eNO) in patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 434s
Year: 2002

Future perspectives on exhaled biomarkers
Source: Eur Respir Monogr 2010; 49: 237-246
Year: 2010


Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008

Hydrogen peroxide in exhaled breath condensate and exhaled nitric oxide as non-invasive markers for childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009